Mylan N.V. (NASDAQ:MYL) was the target of some unusual options trading activity on Thursday. Traders bought 18,942 call options on the stock. This is an increase of approximately 589% compared to the average daily volume of 2,749 call options.
MYL has been the topic of several analyst reports. Deutsche Bank AG reduced their target price on shares of Mylan N.V. from $52.00 to $51.00 and set a “buy” rating on the stock in a report on Tuesday, April 18th. UBS AG reaffirmed a “buy” rating and issued a $46.00 target price (down previously from $50.00) on shares of Mylan N.V. in a report on Thursday. Morgan Stanley reduced their target price on shares of Mylan N.V. from $52.00 to $36.00 and set an “equal weight” rating on the stock in a report on Monday. Royal Bank Of Canada set a $41.00 target price on shares of Mylan N.V. and gave the company a “hold” rating in a report on Saturday, May 13th. Finally, Zacks Investment Research raised shares of Mylan N.V. from a “sell” rating to a “hold” rating in a report on Thursday, May 25th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $47.83.
Mylan N.V. (NASDAQ:MYL) traded down 4.37% during trading on Friday, reaching $30.88. 11,080,764 shares of the company were exchanged. Mylan N.V. has a 52-week low of $29.58 and a 52-week high of $49.42. The stock has a market capitalization of $16.52 billion, a PE ratio of 24.96 and a beta of 1.27. The firm’s 50 day moving average is $37.34 and its 200 day moving average is $39.01.
Mylan N.V. (NASDAQ:MYL) last issued its earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by $0.08. Mylan N.V. had a return on equity of 22.42% and a net margin of 5.51%. The company had revenue of $2.96 billion during the quarter, compared to analyst estimates of $3 billion. During the same period in the prior year, the business earned $1.16 earnings per share. Mylan N.V.’s quarterly revenue was up 15.7% on a year-over-year basis. Analysts expect that Mylan N.V. will post $4.68 EPS for the current year.
In other news, President Rajiv Malik sold 25,000 shares of the firm’s stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $1,000,000.00. Following the completion of the transaction, the president now owns 799,855 shares of the company’s stock, valued at $31,994,200. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Anthony Mauro sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $400,000.00. Following the completion of the transaction, the insider now directly owns 140,653 shares of the company’s stock, valued at approximately $5,626,120. The disclosure for this sale can be found here. Company insiders own 0.69% of the company’s stock.
A number of large investors have recently modified their holdings of MYL. First Personal Financial Services raised its stake in shares of Mylan N.V. by 33.2% in the first quarter. First Personal Financial Services now owns 2,733 shares of the company’s stock valued at $107,000 after buying an additional 681 shares in the last quarter. Global X Management Co. LLC raised its stake in shares of Mylan N.V. by 91.6% in the first quarter. Global X Management Co. LLC now owns 3,015 shares of the company’s stock valued at $118,000 after buying an additional 1,441 shares in the last quarter. Ropes Wealth Advisors LLC bought a new stake in shares of Mylan N.V. during the first quarter valued at $136,000. Oakworth Capital Inc. raised its stake in shares of Mylan N.V. by 30.7% in the first quarter. Oakworth Capital Inc. now owns 4,255 shares of the company’s stock valued at $166,000 after buying an additional 1,000 shares in the last quarter. Finally, State of Alaska Department of Revenue bought a new stake in shares of Mylan N.V. during the first quarter valued at $188,000. 70.19% of the stock is currently owned by hedge funds and other institutional investors.
Mylan N.V. Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
What are top analysts saying about Mylan N.V.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Mylan N.V. and related companies.